Trillium Renewable Chemicals | $13,000,000 | (May 7, 2026)
RadixArk | $100,000,000 | (May 7, 2026)
Astrada | $3,800,000 | (May 7, 2026)
Certified by Founder
Lodge
Cytospire Therapeutics Ltd
start up
- 07/05/2026
- Series A
- $82,984,705
Cytospire Therapeutics is developing a portfolio of next generation immune cell engagers
- Industry Biotechnology Research
- Website https://www.cytospire.com/
- LinkedIn https://www.linkedin.com/company/cytospire-therapeutics-ltd/
Related People
Natalie MountFounder
United Kingdom -
London, England
Immuno-Oncology
Cell and Gene Therapy
Biotech leadership
Preclinical Development
Translational Medicine
Clinical Development
XCaliber Health | $6,500,000 | (May 7, 2026)
QuantWare | $178,775,560 | (May 7, 2026)
MOSH | $13,000,000 | (May 7, 2026)
InstaSwitch | $4,700,000 | (May 7, 2026)
Smartness | $55,270,590 | (May 7, 2026)
Scout Space | $18,000,000 | (May 7, 2026)
Altara | $7,000,000 | (May 7, 2026)
District | $14,700,000 | (May 7, 2026)